Paradigm Biopharmaceuticals Ltd has released a press release.
Reinstatement to Official Quotation
Filed with ASX ·
6ix hasn’t read this filing yet.
Paradigm Biopharmaceuticals Ltd. on 6ix
Earlier from Paradigm Biopharmaceuticals
- Paradigm completes $35m raising
- Paradigm Reports Very Encouraging Real World Data
- Paradigm receives clarity on US regulatory pathway
- Paradigm Latest Corporate Presentation
- Voluntary Suspension
Later from Paradigm Biopharmaceuticals
- EAP treatment completed and Orphan Status achieved for MPS-I
- Block trade to institutional investors
- S&P DJI Announces June 2020 Quarterly Rebalance
- New financial year update
- Eap - 65% pain reduction in 10 oa patients in usa
Follow Paradigm Biopharmaceuticals into a list and get an email when it puts out news.
Follow Paradigm Biopharmaceuticals